Log In
Print
BCIQ
Print
Print this Print this
 

TEN-010

  Manage Alerts
Collapse Summary General Information
Company Tensha Therapeutics Inc.
DescriptionSmall molecule bromodomain inhibitor that is selective for the bromodomain and extra-terminal domain (BET) protein family (BRD4, BRD3, BRD2 and BRDT)
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationSolid tumors
Indication DetailsTreat advanced solid tumors in patients refractory or intolerant to standard/approved therapies
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today